Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

As a long-term holder, I don’t especially care about the minor price movements you’re preoccupied with; rather, I’m interested in the big events that could cause MNTA’s shares to be radically repriced, such as getting FDA approval for Copaxone. Since charts are utterly useless for predicting the timing or the outcome of such events, there’s little reason for me to pay attention to them. Regards, Dew

p.s. I presume that some readers of this board find your TA of value, and that’s why I’m allowing it.